Skip to main content

UBS Group AG

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in INO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$434,389
+$137,584 QoQ
Shares Held
249,650
+46.4% QoQ
Ownership
0.303%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 99.94872821950732.ToString("F0")% Shared 0.ToString("F0")% None 0.05127178049268977.ToString("F0")%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. INO ranks #298 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $434,389 249,650
2025-12-31 $296,805 170,579
2025-09-30 $685,763 293,062
2025-06-30 $407,344 199,679
2025-03-31 $338,822 207,867
2024-12-31 $323,861 176,974
2024-09-30 $79,272 13,715
2024-06-30 $221,318 27,391
2024-03-31 $26,593 1,916